Literature DB >> 26906397

The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women.

Adrienne O'Neil1, Aaron J Fisher2, Katherine J Kibbey3, Felice N Jacka4, Mark A Kotowicz5, Lana J Williams6, Amanda L Stuart6, Michael Berk7, Paul A Lewandowski6, John J Atherton8, Craig B Taylor9, Julie A Pasco10.   

Abstract

BACKGROUND: Depression is widely considered to be an independent and robust predictor of Coronary Heart Disease (CHD), however is seldom considered in the context of formal risk assessment. We assessed whether the addition of depression to the Framingham Risk Equation (FRE) improved accuracy for predicting 10-year CHD in a sample of women.
DESIGN: A prospective, longitudinal design comprising an age-stratified, population-based sample of Australian women collected between 1993 and 2011 (n=862).
METHODS: Clinical depressive disorder was assessed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID-I/NP), using retrospective age-of-onset data. A composite measure of CHD included non-fatal myocardial infarction, unstable angina coronary intervention or cardiac death. Cox proportional-hazards regression models were conducted and overall accuracy assessed using area under receiver operating characteristic (ROC) curve analysis.
RESULTS: ROC curve analyses revealed that the addition of baseline depression status to the FRE model improved its overall accuracy (AUC:0.77, Specificity:0.70, Sensitivity:0.75) when compared to the original FRE model (AUC:0.75, Specificity:0.73, Sensitivity:0.67). However, when calibrated against the original model, the predicted number of events generated by the augmented version marginally over-estimated the true number observed.
CONCLUSIONS: The addition of a depression variable to the FRE equation improves the overall accuracy of the model for predicting 10-year CHD events in women, however may over-estimate the number of events that actually occur. This model now requires validation in larger samples as it could form a new CHD risk equation for women.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Depression; Prevention; Risk factor assessment; Women

Mesh:

Year:  2016        PMID: 26906397     DOI: 10.1016/j.ypmed.2016.02.028

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  5 in total

Review 1.  Do Statins Have Antidepressant Effects?

Authors:  Ole Köhler-Forsberg; Christiane Gasse; Michael Berk; Søren Dinesen Østergaard
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

2.  Prognostic value of exercise capacity among patients with treated depression: The Henry Ford Exercise Testing (FIT) Project.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Sherif Sakr; Michael J Blaha; Clinton A Brawner; Jonathan K Ehrman; Steven J Keteyian; Mouaz H Al-Mallah
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

3.  Association of the Interaction Between Smoking and Depressive Symptom Clusters With Coronary Artery Calcification: The CARDIA Study.

Authors:  Allison J Carroll; Reto Auer; Laura A Colangelo; Mercedes R Carnethon; David R Jacobs; Jesse C Stewart; Rachel Widome; John Jeffrey Carr; Kiang Liu; Brian Hitsman
Journal:  J Dual Diagn       Date:  2017-01-27

4.  Inflammation and Coronary Heart Disease Risk in Patients with Depression in China Mainland: A Cross-Sectional Study.

Authors:  Lina Zhou; Xiancang Ma; Wei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-09       Impact factor: 2.570

5.  Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder.

Authors:  Roger C M Ho; Anna C Chua; Bach X Tran; Carol C Choo; Syeda Fabeha Husain; Giang T Vu; Roger S McIntyre; Cyrus S H Ho
Journal:  Int J Environ Res Public Health       Date:  2018-09-21       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.